Gastrointestinal Symptoms Associated With Vaping

Vaping is most often associated with respiratory effects, but gastrointestinal symptoms can also occur in people who use electronic cigarettes or other vaping products. Nausea, vomiting, abdominal pain, and diarrhea have all been reported, particularly in patients with vaping-related illness.

These symptoms may result from nicotine exposure, irritation from aerosolized chemicals, systemic inflammation, or more serious conditions such as e-cigarette or vaping product use-associated lung injury (EVALI).

Recognizing the gastrointestinal effects of vaping is important because digestive symptoms may sometimes appear before significant respiratory problems develop.

 

How Vaping Can Affect the Gastrointestinal System

Electronic cigarettes and vaping devices heat a liquid or other substance to produce an aerosol that is inhaled into the lungs. Depending on the product, the aerosol may contain nicotine, flavoring chemicals, solvents, metals, tetrahydrocannabinol (THC), and other substances.

Although inhalation occurs through the respiratory tract, the effects of these substances are not necessarily limited to the lungs. Chemicals absorbed across the pulmonary circulation can enter the bloodstream and affect multiple organ systems, including the gastrointestinal tract.

Some aerosol can also deposit in the mouth and throat and subsequently be swallowed. Saliva containing aerosol particles, nicotine, flavoring compounds, and other substances can therefore enter the stomach and gastrointestinal tract directly.

The exact mechanisms responsible for gastrointestinal symptoms vary depending on the product being used, the amount of nicotine or THC involved, frequency of vaping, individual susceptibility, and whether vaping-related illness has developed.

Common gastrointestinal complaints associated with vaping include:

• Nausea
• Vomiting
• Abdominal pain
• Stomach discomfort
• Diarrhea
• Reduced appetite
• Loss of appetite
• Dehydration
• Weight loss

These symptoms are particularly important in the evaluation of suspected EVALI. During the major EVALI outbreak, CDC surveillance found that gastrointestinal complaints were common among affected patients. In one CDC analysis, 77% of patients with EVALI had gastrointestinal symptoms such as abdominal pain, nausea, vomiting, or diarrhea. In some patients, digestive symptoms occurred before respiratory symptoms developed.

Nausea

Nausea is one of the most frequently reported gastrointestinal symptoms associated with vaping. It may occur shortly after vaping or develop as part of a broader vaping-related illness.

Nicotine is an important potential cause. When nicotine enters the bloodstream, it affects nicotinic acetylcholine receptors throughout the body. At lower doses, nicotine can produce stimulation, while larger exposures can produce nausea, dizziness, sweating, abdominal discomfort, and vomiting.

The amount of nicotine delivered by a vaping device varies considerably. Factors that influence exposure include the nicotine concentration of the liquid, device power, inhalation technique, frequency of use, and number of puffs taken.

High-concentration nicotine products can deliver substantial doses, particularly when used repeatedly over a short period.

Nausea may therefore occur when a person:

• Uses a high-nicotine vaping product
• Takes frequent or prolonged puffs
• Begins vaping without nicotine tolerance
• Switches to a stronger nicotine concentration
• Uses multiple nicotine-containing products
• Vapes repeatedly over a short period

Nausea can also occur as part of EVALI rather than from nicotine alone. A clinical report involving patients with vaping-related pulmonary illness in Illinois and Wisconsin found nausea in approximately 66% of patients.

For this reason, nausea accompanied by cough, shortness of breath, chest discomfort, fever, or other systemic symptoms should not automatically be attributed to simple nicotine exposure.

Vomiting

Vomiting may occur when nausea becomes severe or when vaping produces significant systemic effects. Nicotine stimulates both the autonomic nervous system and areas of the central nervous system involved in nausea and vomiting. Excessive nicotine exposure can therefore trigger repeated vomiting.

Other chemicals contained within vaping aerosols may also contribute to gastrointestinal irritation, although the degree to which individual aerosol constituents cause specific digestive symptoms remains under investigation.

Vomiting becomes clinically important when it is persistent because repeated fluid loss can lead to dehydration and electrolyte disturbances.

Signs that vomiting may be causing significant dehydration include:

• Dry mouth
• Increased thirst
• Reduced urine output
• Dark urine
• Dizziness
• Weakness
• Tachycardia
• Orthostatic symptoms

In severe cases, electrolyte abnormalities may develop. Patients who are already experiencing respiratory illness may tolerate dehydration poorly because tachycardia, weakness, and metabolic disturbances can complicate the overall clinical picture.

Vomiting is also common in EVALI. In one major clinical series, approximately 61% of affected patients experienced vomiting.

Abdominal Pain

Abdominal pain or stomach discomfort can develop in people who vape, although the exact cause may vary considerably between patients.

Nicotine can affect gastrointestinal motility and autonomic activity, potentially producing cramping or generalized abdominal discomfort. Swallowed aerosol components may also irritate the gastrointestinal tract.

Abdominal pain associated with vaping-related illness may range from mild epigastric discomfort to more diffuse abdominal pain.

The location of the pain is not specific enough to determine whether vaping is responsible. Appendicitis, gallbladder disease, pancreatitis, gastroenteritis, inflammatory bowel disease, urinary disorders, and numerous other medical conditions can produce similar symptoms.

Vaping history should therefore be treated as one part of the clinical assessment rather than as proof that vaping caused the abdominal complaint. Abdominal pain has been repeatedly documented among patients with EVALI.

Some EVALI patients have presented with gastrointestinal complaints significant enough that an abdominal condition was initially suspected. Clinical literature has also described situations in which imaging performed for abdominal symptoms incidentally revealed abnormalities involving the lower portions of the lungs.

Diarrhea

Diarrhea is another gastrointestinal symptom associated with vaping-related illness. Like nausea and vomiting, diarrhea may reflect systemic exposure to nicotine or other aerosol constituents. It may also occur during the inflammatory response associated with EVALI.

Diarrhea alone is highly nonspecific. Viral infections, bacterial gastroenteritis, dietary changes, medications, anxiety, inflammatory bowel disorders, and numerous other conditions can produce diarrhea.

However, diarrhea becomes more clinically meaningful in the context of a patient who also has:

• Recent vaping exposure
• Persistent nausea or vomiting
• Cough
• Shortness of breath
• Chest pain
• Fever
• Chills
• Fatigue
• Weight loss
• Hypoxemia

In the Illinois and Wisconsin EVALI case series, approximately 44% of patients experienced diarrhea.

When vomiting and diarrhea occur together, fluid and electrolyte losses may become significant. Patients with respiratory compromise can deteriorate more rapidly when dehydration accompanies pulmonary disease.

Loss of Appetite

Reduced appetite may develop for several reasons in people experiencing vaping-related gastrointestinal symptoms. Nausea naturally decreases the desire to eat. Abdominal discomfort, vomiting, diarrhea, fever, and generalized malaise can further suppress appetite.

Nicotine itself can also influence appetite regulation. Nicotine affects neural pathways involved in hunger and satiety, which helps explain why appetite suppression has historically been associated with nicotine-containing tobacco products.

When someone is acutely ill, however, loss of appetite becomes more concerning because decreased food intake may contribute to weakness, dehydration, and unintended weight loss. Loss of appetite occurring with respiratory symptoms should therefore be considered part of the overall clinical picture rather than viewed as an isolated digestive complaint.

Weight Loss

Weight loss has been reported among some patients with vaping-related illness, particularly when symptoms continue for days or weeks.

Several factors may contribute:

• Reduced appetite
• Recurrent nausea
• Persistent vomiting
• Diarrhea
• Increased metabolic demands associated with illness
• Reduced oral intake
• Dehydration

During the EVALI outbreak, constitutional symptoms such as fever, chills, and weight loss frequently accompanied respiratory and gastrointestinal complaints. Unexplained weight loss in someone who vapes should therefore prompt consideration of the entire clinical presentation.

Weight loss alone does not establish a connection with vaping, but persistent weight loss accompanied by cough, dyspnea, nausea, vomiting, or abdominal symptoms deserves medical evaluation.

Nicotine and Gastrointestinal Symptoms

Nicotine is one of the most important explanations for acute gastrointestinal symptoms associated with vaping. Once inhaled, nicotine is rapidly absorbed into the bloodstream. It then affects the central nervous system, cardiovascular system, and autonomic nervous system.

Gastrointestinal manifestations of excessive nicotine exposure can include:

• Nausea
• Vomiting
• Abdominal pain
• Increased salivation
• Diarrhea

Other systemic findings may include dizziness, headache, sweating, tremors, tachycardia, and weakness. The severity of symptoms depends partly on the dose. Someone who rarely uses nicotine may experience nausea after an exposure that produces little noticeable gastrointestinal effect in a person who regularly uses nicotine.

Tolerance does not eliminate the potential for toxicity. Experienced users may still develop symptoms when nicotine exposure increases substantially.

A person may unintentionally increase exposure by switching products, changing devices, increasing nicotine concentration, vaping continuously, or combining vaping with cigarettes, nicotine pouches, or other nicotine-containing products.

Why High-Nicotine Vapes May Cause More Symptoms

Modern vaping products can vary greatly in nicotine concentration and delivery efficiency.

Some devices use nicotine salts, which can make relatively high concentrations of nicotine easier to inhale. Because the aerosol may feel less harsh than traditional free-base nicotine at comparable concentrations, users may inhale repeatedly without immediately recognizing how much nicotine they are receiving.

A person who experiences nausea or dizziness while vaping may describe the sensation as being “nic sick.” Although this is not a medical diagnosis, the term is commonly used to describe symptoms resulting from excessive nicotine exposure.

Typical symptoms may include nausea, dizziness, headache, sweating, abdominal discomfort, and occasionally vomiting.

Mild symptoms may improve when nicotine exposure stops. Persistent, severe, or worsening symptoms require further evaluation because other conditions may be responsible.

Vaping on an Empty Stomach

Some users report that nausea or abdominal discomfort feels worse when vaping on an empty stomach. There is limited evidence defining exactly how fasting changes vaping-related gastrointestinal symptoms, but several factors could contribute.

Nicotine can produce nausea regardless of food intake. A person who has not eaten may also be more sensitive to dizziness, weakness, or lightheadedness, which can make the overall experience feel more severe.

Nicotine-related appetite suppression may create another problem. A person who regularly vapes instead of eating may unintentionally reduce caloric and fluid intake, potentially worsening weakness or gastrointestinal discomfort.

Eating food should not be viewed as a way to make excessive nicotine exposure safe. Recurrent nausea after vaping suggests that the exposure itself should be addressed.

Swallowed Vaping Aerosol

Not all vaping aerosol that enters the mouth reaches the lungs. Some particles deposit in the oral cavity and throat. These substances can mix with saliva and be swallowed, allowing aerosol constituents to enter the gastrointestinal tract.

Vaping liquids may contain substances such as:

• Propylene glycol
• Vegetable glycerin
• Flavoring chemicals
• Nicotine
• Metals or other contaminants
• THC or cannabinoid compounds in some products

The health effects of chronic exposure to the many individual chemicals and chemical mixtures contained in vaping aerosols remain incompletely understood. Reviews of e-cigarette health effects have described gastrointestinal symptoms including epigastric pain, nausea, vomiting, and diarrhea, although evidence regarding specific mechanisms and long-term digestive effects remains limited.

This uncertainty is important. The presence of a chemical in an aerosol does not automatically prove that it caused a patient’s gastrointestinal symptoms.

Gastrointestinal Symptoms and EVALI

One of the most important clinical connections between vaping and gastrointestinal symptoms involves e-cigarette or vaping product use-associated lung injury, commonly abbreviated EVALI.

EVALI became widely recognized during an outbreak in the United States in 2019. The disorder involves acute or subacute lung injury associated with recent use of vaping products. Although EVALI primarily affects the respiratory system, gastrointestinal symptoms are extremely common.

The CDC reported that among one group of patients with EVALI:

• 95% experienced respiratory symptoms
• 77% experienced gastrointestinal symptoms
• 85% experienced constitutional symptoms

Note: The gastrointestinal complaints included abdominal pain, nausea, vomiting, and diarrhea. This pattern demonstrates why clinicians should not think of EVALI purely as a respiratory illness.

Gastrointestinal Symptoms May Come First

One of the more clinically important aspects of EVALI is that gastrointestinal symptoms can precede respiratory symptoms. A patient may initially experience nausea, vomiting, diarrhea, or abdominal discomfort without recognizing that the illness involves the lungs.

Later, respiratory symptoms may develop, including:

• Cough
• Shortness of breath
• Chest pain
• Increased work of breathing
• Hypoxemia

The CDC specifically reported that gastrointestinal symptoms preceded respiratory complaints in some patients with EVALI. This presentation can complicate diagnosis because early symptoms may resemble gastroenteritis, food poisoning, or another abdominal condition.

For respiratory therapists and other healthcare professionals, obtaining a thorough vaping history can therefore be important even when the patient’s initial complaint is gastrointestinal.

Constitutional Symptoms With EVALI

EVALI commonly produces constitutional symptoms in addition to respiratory and gastrointestinal problems.

These may include:

• Fever
• Chills
• Fatigue
• Malaise
• Weight loss

The combination can resemble an infectious illness. For example, a patient may present with fever, vomiting, diarrhea, cough, and shortness of breath. Without asking about vaping exposure, clinicians may initially focus primarily on pneumonia, influenza, or gastrointestinal infection.

EVALI remains a diagnosis of exclusion, meaning that other plausible causes of the patient’s findings must be considered and investigated. CDC guidance emphasizes evaluating alternative diagnoses rather than assuming symptoms are caused by vaping exposure alone.

Respiratory Symptoms That May Accompany Gastrointestinal Symptoms

When gastrointestinal symptoms are related to significant vaping-associated illness, respiratory complaints may appear simultaneously or develop later. Common respiratory findings include cough, dyspnea, and chest pain.

In the Illinois and Wisconsin EVALI case series, the most frequently reported respiratory symptoms were cough and shortness of breath, each occurring in approximately 85% of patients. Chest pain occurred in approximately 52%.

Some patients may initially underestimate their breathing problems because nausea, abdominal pain, or vomiting are more noticeable. Healthcare professionals should therefore assess respiratory status even when gastrointestinal symptoms dominate the presentation.

Importance of Oxygen Saturation

Pulse oximetry is important when evaluating a patient with suspected vaping-related lung injury. A patient may present primarily with nausea, vomiting, or abdominal pain while also having impaired oxygenation from underlying pulmonary injury.

During the EVALI outbreak, reduced oxygen saturation was common among hospitalized patients. CDC clinical guidance therefore recommended measuring oxygen saturation as part of the physical evaluation when vaping-related lung injury was suspected.

A normal appearance does not completely exclude pulmonary disease, especially early in the course of illness. For respiratory therapists, recognition of unexplained hypoxemia combined with gastrointestinal and constitutional symptoms should increase suspicion of a broader cardiopulmonary process.

Dehydration From Vomiting and Diarrhea

Significant vomiting and diarrhea can cause dehydration, particularly when symptoms persist. Fluid loss can reduce circulating blood volume and produce compensatory cardiovascular responses.

Possible findings include:

• Tachycardia
• Hypotension
• Orthostatic dizziness
• Reduced urine production
• Dry mucous membranes
• Weakness

Electrolyte abnormalities may also occur. One EVALI case series reported mild hyponatremia, hypokalemia, or both in some patients. The abnormalities were not necessarily caused directly by vaping and could have reflected illness, vomiting, diarrhea, reduced intake, or other physiologic disturbances.

Dehydration can also increase heart rate, making it important to interpret tachycardia in the context of the patient’s entire presentation.

Can Vaping Cause Acid Reflux?

Some people who vape report heartburn or symptoms consistent with gastroesophageal reflux, but the relationship between vaping and gastroesophageal reflux disease is not as clearly established as the relationship between vaping and symptoms such as nausea or vomiting.

Nicotine has physiologic effects that could potentially influence reflux. Nicotine exposure has been associated with changes in gastrointestinal motility and lower esophageal sphincter function in tobacco research.

However, symptoms such as heartburn have many possible causes, including diet, obesity, alcohol use, medications, hiatal hernia, and existing gastroesophageal reflux disease.

It is therefore more accurate to state that vaping and nicotine exposure may contribute to digestive discomfort in some individuals rather than claiming that vaping is always the cause of reflux disease. Persistent heartburn should be evaluated based on the patient’s overall medical history and symptoms.

Can Vaping Cause Stomach Ulcers?

There is currently insufficient evidence to say that vaping directly causes peptic ulcers. Peptic ulcer disease is commonly associated with Helicobacter pylori infection and use of medications such as nonsteroidal anti-inflammatory drugs.

Smoking conventional cigarettes is known to adversely affect gastrointestinal health and can interfere with ulcer healing, but the long-term gastrointestinal consequences of vaping are less clearly established.

A person who vapes and develops persistent upper abdominal pain should not assume that the symptom is simply caused by vaping. Evaluation may be necessary to rule out gastritis, ulcer disease, gallbladder disorders, pancreatitis, reflux, or other gastrointestinal conditions.

Vaping and Bowel Function

Nicotine can influence autonomic activity and gastrointestinal motility, which may help explain why some individuals notice changes in bowel habits associated with nicotine use.

Some users report an increased urge to have a bowel movement after nicotine exposure, while others experience diarrhea or abdominal cramping.

However, bowel habits vary considerably among individuals, and changes should not automatically be attributed to vaping. Persistent diarrhea, blood in the stool, severe abdominal pain, fever, or unexplained weight loss requires medical evaluation regardless of whether the individual vapes.

THC Vaping and Gastrointestinal Symptoms

Not every vaping product contains nicotine.

Some vaping products contain THC, the primary psychoactive component of cannabis. THC-containing products were strongly associated with the 2019 EVALI outbreak, particularly products obtained through informal sources. CDC investigations identified vitamin E acetate as strongly linked to the outbreak, especially in certain THC-containing products.

THC exposure also creates additional considerations when evaluating persistent nausea and vomiting. Long-term or frequent cannabis use can be associated with cannabinoid hyperemesis syndrome, a condition characterized by recurrent episodes of severe nausea and vomiting.

Therefore, a patient who vapes THC and develops vomiting could have several possible explanations, including EVALI, excessive exposure, cannabinoid hyperemesis syndrome, an unrelated gastrointestinal disorder, or another illness. The clinical history must distinguish between these possibilities.

Obtaining a Vaping History

When gastrointestinal symptoms occur alongside respiratory or constitutional symptoms, obtaining a detailed vaping history can provide important diagnostic information.

Healthcare providers may ask about:

• Whether the patient currently vapes
• What substances are used
• Whether products contain nicotine, THC, or both
• Frequency of use
• Duration of vaping
• Nicotine concentration
• Recent changes in products or devices
• Source of the products
• Time of most recent use

Note: CDC guidance has recommended asking patients about vaping in a confidential and nonjudgmental manner when they present with respiratory, gastrointestinal, or constitutional symptoms suggestive of EVALI. This approach is particularly important when evaluating adolescents and young adults who may initially hesitate to disclose substance use.

Differential Diagnosis

Gastrointestinal symptoms are common and nonspecific, so vaping should not automatically be considered the cause. A patient experiencing nausea, vomiting, abdominal pain, or diarrhea could have a wide range of disorders.

Possible causes include:

• Viral gastroenteritis
• Foodborne illness
• Medication side effects
• Pregnancy
• Appendicitis
• Cholecystitis
• Pancreatitis
• Peptic ulcer disease
• Gastroesophageal reflux
• Inflammatory bowel disease
• Urinary tract disorders
• Metabolic abnormalities
• Drug or toxin exposure
• Cannabis-related illness
• EVALI

Note: Respiratory infections may also produce gastrointestinal symptoms, particularly when accompanied by fever and systemic illness. For this reason, EVALI is considered a diagnosis of exclusion. There is no single laboratory test that proves the diagnosis.

When Gastrointestinal Symptoms Require Medical Attention

Mild nausea after nicotine exposure may resolve when vaping stops, but persistent or severe symptoms require greater concern.

Medical evaluation is especially important when gastrointestinal symptoms occur with:

• Shortness of breath
• Persistent cough
• Chest pain
• Low oxygen saturation
• Fever
• Severe weakness
• Repeated vomiting
• Inability to keep fluids down
• Signs of dehydration
• Severe abdominal pain
• Confusion
• Fainting
• Blood in vomit or stool

Note: Respiratory symptoms following recent vaping exposure are particularly important because EVALI can progress to significant hypoxemic respiratory failure. Patients with significant breathing difficulty, cyanosis, altered mental status, severe chest pain, or other signs of respiratory compromise require urgent evaluation.

Clinical Considerations for Respiratory Therapists

Respiratory therapists may encounter patients with vaping-related illness in the emergency department, hospital, pulmonary clinic, or intensive care unit. Although respiratory assessment is a primary responsibility, gastrointestinal symptoms can provide valuable clues.

A young or otherwise healthy patient presenting with unexplained hypoxemia, cough, dyspnea, nausea, vomiting, and abdominal discomfort should prompt consideration of vaping exposure as part of the clinical history.

Important respiratory assessments may include:

• Respiratory rate
• Work of breathing
• Breath sounds
• Oxygen saturation
• Oxygen requirements
• Arterial blood gas results when indicated
• Chest imaging findings
• Response to supplemental oxygen

The presence of significant gastrointestinal symptoms should not distract from assessment of oxygenation and ventilation.

Likewise, respiratory findings should not cause gastrointestinal complaints to be ignored. Vomiting, diarrhea, and inadequate intake can contribute to dehydration and metabolic abnormalities that complicate pulmonary illness.

Can Symptoms Improve After Stopping Vaping?

Symptoms caused by acute nicotine exposure may improve after vaping stops and nicotine levels decline. However, the time course depends on the underlying cause.

A person experiencing mild nausea from nicotine may improve relatively quickly, while someone with EVALI may require hospitalization, supplemental oxygen, and other medical treatment.

Persistent gastrointestinal symptoms should therefore not be managed solely by waiting for nicotine to leave the body.

The presence of respiratory symptoms, fever, severe vomiting, dehydration, or worsening illness warrants medical assessment. Stopping vaping also prevents continued exposure to the substance that may be contributing to symptoms.

Preventing Vaping-Related Gastrointestinal Effects

The most reliable way to prevent gastrointestinal symptoms caused by vaping is to avoid vaping products. Reducing exposure may decrease symptoms, but it does not eliminate the potential health risks associated with aerosol inhalation.

Individuals who are dependent on nicotine may experience withdrawal symptoms after stopping, including irritability, anxiety, difficulty concentrating, increased appetite, and strong cravings.

Nicotine dependence can make quitting difficult, so some individuals may benefit from evidence-based smoking or vaping cessation support.

From a clinical standpoint, the goal is not simply to manage nausea or stomach discomfort while continuing the exposure. Identifying and addressing the underlying vaping behavior is an important part of preventing recurrent symptoms.

Final Thoughts

Gastrointestinal symptoms are an important but sometimes overlooked consequence associated with vaping. Nausea, vomiting, abdominal pain, diarrhea, appetite loss, dehydration, and weight loss may occur after nicotine exposure or as part of a more serious vaping-related illness.

These symptoms are particularly significant in EVALI, where gastrointestinal complaints may occur alongside or even before respiratory symptoms.

Because digestive complaints have many possible causes, vaping history should be considered within the broader clinical assessment rather than used as the sole explanation. Persistent gastrointestinal symptoms, especially when accompanied by cough, dyspnea, chest pain, fever, or hypoxemia, should prompt appropriate medical evaluation.